Clinical influenza activity in Europe is still low, with influenza B virus being dominant: an update from EISSA Meijer, JM Falcao, JC Jong, J Kyncl, TJ Meerhoff, LE Meuwissen, A Nicoll, Velden, WJ Paget18/01/2006Journal Article
Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme.M Oosten, SC Greeff, L Spanjaard, LM Schouls18-01-2006Journal Article
Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018A Meijer, CM Swaan, M Voerknecht, E Jusic, S Brink, LA Wijsman, BCG Voordouw, GA Donker, J Sleven, JW Dorigo-Zetsma, S Svraka, M Boven, MR Haverkate, A Timen, JT Dissel, MP Koopmans, TM Bestebroer, RAM Fouchier23/04/2018Journal Article
Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015JP Bil, PA Schrooders, M Prins, PM Kouw, JHE Klomp, M Scholing, LPHM Huijbregts, GJB Sonder, CHFM Waegemaekers, HJC Vries, W Meijer, FR Zuure, A Tostmann26/03/2018Journal Article
HIV and STIs increaing in the Netherlands according to latest surveillance dataELM Op de Coul, IM Boer, FDH Koedijk, MJW Laar18/01/2006Journal Article
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.A Cassini, E Colzani, A Pini, MJ Mangen, D Plass, SA McDonald, G Maringhini, A Lier, JA Haagsma, AH Havelaar, et.al.2018-04-30Journal Article
Epidemiological and virological assessment of influenza activity in Europe during the 2003-2004 seasonWJ Paget, TJ Meerhoff, A Meijer26/06/2006Journal Article
Clostridium difficile PCR ribotype 027 outbreaks in the Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limitedS Hof, T Kooi, R Berg, EJ Kuijper, DW Notermans18/01/2006Journal Article
Strategies for achieving viral hepatitis C micro-elimination in the Netherlands.PAM Kracht, JE Arends, KJ Erpecum, A Urbanus, JA Willemse, AIM Hoepelman, EA Croes2018-10-08Journal Article
Differences in the toxicity of cerium dioxide nanomaterials after inhalation can be explained by lung deposition, animal species and nanoforms.S Dekkers, L Ma-Hock, I Lynch, M Russ, MR Miller, RPF Schins, J Keller, WH Jong, FR Cassee, et.al.2018-10-08Journal Article